Nevertheless, because IgM antibody titers targeting OSE were not determined in these studies it is not possible to conclude any association between levels of OSE-specific IgM to NASH development in these cohorts. This evidence concerns the gene CD40LG and metabolic dysfunction-associated steatohepatitis.